{"filing":{"accession_number":"0000015847-26-000009","cik":"0000015847","ticker":"BUKS","company_name":"BUTLER NATIONAL CORP","form":"8-K","filing_date":"2026-06-01","report_date":null,"primary_document":"buks-20260601.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/buks-20260601.htm"},"events":[{"id":7649,"run_id":6724,"accession_number":"0000015847-26-000009","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"summary":"The disclosure reveals that CEO Christopher J. Reedy is undergoing medical treatment at Mayo Clinic, which could materially affect investor assessment of leadership continuity and operational risk. While the company emphasizes his continued active engagement and the strength of the leadership team, the fact that treatment may \"periodically require time away from the office\" and the Board's explicit statements of support suggest a material health-related concern about the CEO. This does not fit neatly into exec_departure (he remains CEO) or exec_appointment, but the medical situation and its potential operational implications warrant material disclosure under Item 8.01.","company_name":"BUTLER NATIONAL CORP","ticker":"BUKS","filing_date":"2026-06-01","form":"8-K","submitted_at":null,"items":[{"id":2927,"accession_number":"0000015847-26-000009","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"reasoning":"The disclosure reveals that CEO Christopher J. Reedy is undergoing medical treatment at Mayo Clinic, which could materially affect investor assessment of leadership continuity and operational risk. While the company emphasizes his continued active engagement and the strength of the leadership team, the fact that treatment may \"periodically require time away from the office\" and the Board's explicit statements of support suggest a material health-related concern about the CEO. This does not fit neatly into exec_departure (he remains CEO) or exec_appointment, but the medical situation and its potential operational implications warrant material disclosure under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T02:10:25.896253+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2927,"accession_number":"0000015847-26-000009","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"reasoning":"The disclosure reveals that CEO Christopher J. Reedy is undergoing medical treatment at Mayo Clinic, which could materially affect investor assessment of leadership continuity and operational risk. While the company emphasizes his continued active engagement and the strength of the leadership team, the fact that treatment may \"periodically require time away from the office\" and the Board's explicit statements of support suggest a material health-related concern about the CEO. This does not fit neatly into exec_departure (he remains CEO) or exec_appointment, but the medical situation and its potential operational implications warrant material disclosure under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T02:10:25.896253+00:00","company_name":"BUTLER NATIONAL CORP","ticker":"BUKS","filing_date":"2026-06-01"}]}